FDA Peptide Update: Category 2 Removals Explained Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law BPC 157: Experimental Peptide Creates Risk for Athletes In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few Peptides may soon be easier to get amid RFK Jr.'s push, but experts warn of risks